WO1993014814A1 - Method and apparatus for alleviating and diagnosing symptoms of heart block - Google Patents
Method and apparatus for alleviating and diagnosing symptoms of heart block Download PDFInfo
- Publication number
- WO1993014814A1 WO1993014814A1 PCT/US1993/000509 US9300509W WO9314814A1 WO 1993014814 A1 WO1993014814 A1 WO 1993014814A1 US 9300509 W US9300509 W US 9300509W WO 9314814 A1 WO9314814 A1 WO 9314814A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- heart
- stimuli
- subthreshold
- block
- electrode catheter
- Prior art date
Links
- 206010003671 Atrioventricular Block Diseases 0.000 title claims abstract description 43
- 208000010271 Heart Block Diseases 0.000 title claims abstract description 43
- 238000000034 method Methods 0.000 title claims abstract description 16
- 208000024891 symptom Diseases 0.000 title claims abstract description 11
- 210000002837 heart atrium Anatomy 0.000 claims abstract description 15
- 210000005003 heart tissue Anatomy 0.000 claims abstract description 14
- 230000001746 atrial effect Effects 0.000 claims description 10
- 210000004375 bundle of his Anatomy 0.000 abstract description 37
- 208000011580 syndromic disease Diseases 0.000 abstract description 2
- 208000014526 Conduction disease Diseases 0.000 abstract 1
- 230000002861 ventricular Effects 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 6
- 230000002269 spontaneous effect Effects 0.000 description 6
- 206010006582 Bundle branch block right Diseases 0.000 description 4
- 230000004913 activation Effects 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 230000028161 membrane depolarization Effects 0.000 description 4
- 206010003673 Atrioventricular block complete Diseases 0.000 description 3
- 206010006578 Bundle-Branch Block Diseases 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 210000001992 atrioventricular node Anatomy 0.000 description 3
- 201000007916 right bundle branch block Diseases 0.000 description 3
- 201000002931 third-degree atrioventricular block Diseases 0.000 description 3
- 230000005284 excitation Effects 0.000 description 2
- 208000028867 ischemia Diseases 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 238000000718 qrs complex Methods 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 230000001960 triggered effect Effects 0.000 description 2
- 102100026827 Protein associated with UVRAG as autophagy enhancer Human genes 0.000 description 1
- 101710102978 Protein associated with UVRAG as autophagy enhancer Proteins 0.000 description 1
- 241000364027 Sinoe Species 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000002964 excitative effect Effects 0.000 description 1
- 210000003191 femoral vein Anatomy 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 210000005244 lower chamber Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000034225 regulation of ventricular cardiomyocyte membrane depolarization Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 210000005245 right atrium Anatomy 0.000 description 1
- 210000005241 right ventricle Anatomy 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 210000001013 sinoatrial node Anatomy 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 210000005243 upper chamber Anatomy 0.000 description 1
- 210000001631 vena cava inferior Anatomy 0.000 description 1
- 210000002620 vena cava superior Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
- A61N1/368—Heart stimulators controlled by a physiological parameter, e.g. heart potential comprising more than one electrode co-operating with different heart regions
Definitions
- the present invention generally relates to a method and apparatus for alleviating heart block by restoring and maintaining 1:1 conduction by delivering a subthreshold stimuli to the heart.
- Figure 1 is a diagrammatic, schematic representation of a mammalian heart as seen through a right, lateral thoracotomy and showing the placement of an electrode catheter at the atrioventricular (A-V) junction in the region of the His bundle.
- A-V atrioventricular
- FIGS. 2A, 2B and 2C are diagrammatic representations of three catheters with ring electrodes at the tip and with the ring electrodes being spaced at various distances from the tip.
- the electrode catheters shown in Figure 2 constitute prior art electrode catheters which are suitable for use in the present invention for delivering subthreshold stimuli to the His bundle area.
- Figure 3A is a schematic view of a stimulus generator and other components consisting of isolation and constant current units. Also shown is a diagram of the connection of the stimulus generator to the heart.
- the stimulus generator and components particularly shown in Figure 3A represent a laboratory model which was used to deliver stimuli in the form of a constant current DC pulse in the experiments described herein relating to the present invention.
- Figure 3B is a diagrammatic view of the same generator and components modified to deliver trains of stimuli to the heart.
- the stimulus generator particularly shown in Figure 3B represents a laboratory model of a stimulus generator used in the experiments described herein relating to the present invention.
- Figure 4 is a diagrammatic view shoving a recording of the electrical activity of a mammalian's normal functioning heart and illustrating that the delivery of the stimulus (a DC constant current signal) at the A-V junction in close proximity to the His bundle does not affect conduction through the A-V junction in the normal heart.
- the stimulus a DC constant current signal
- Figure 5 is a recording of the electrical activity of a mammalian's heart wherein the heart has been ischemically damaged due to anterior septal artery ligation and illustrating that the-delivery of the stimulus (a DC constant current signal) in accordance with the present invention induces heart block thereby indicating that this particular heart now is imminently susceptible to heart block.
- the stimulus a DC constant current signal
- Figure 6 is a recording of the electrical activity of amammalian's heart wherein the stimulus (a DC constant current signal) has been delivered at the A-V junction in close proximity to the His bundle in accordance with the present invention of the ischemically damaged heart after the predicted occurrence of a complete A-V heart block and illustrating that the delivery of the stimulus alleviates the symptoms of heart block by restoring 1:1 A-V conduction.
- the stimulus a DC constant current signal
- Figure- 7A, 7B and 7C are diagrammatic views of a recording of the electrical activity of a mammalian's heart with Figure 7B being a continuation from Figure 7A and with Figure 7C being a continuation of Figure 7B.
- Figure 7 illustrates that the delivery of the stimulus alleviates the heart block symptoms, in a manner similar to that described before with respect to Figure 6, but the stimulus in this instance were more particularly a train of intermittent pulses rather than a continuous DC pulse,
- Figure 8A is a recording of electrical activity of a dog's heart wherein the first two traces are standard electrocardiographic leads II (L-2) and aVR and the second trace is the His bundle trace.
- Figure 8B is a recording of electrical activity of a dog's heart where a subthreshold current was delivered to the right ventricular apex.
- heart block syndrome also known as Stokes-Adams attacks
- heart block occurs intermittently and abruptly or paroxysmally.
- the method of the present invention are utilized for alleviating the symptoms of heart block in one aspect, and the method of the present invention are utilized to diagnose future or impending susceptibility of heart block in one other aspect.
- a stimulus is continuously delivered via a single electrode catheter to the A-V junction in close proximity to the His bundle and the delivery of these stimuli alleviates the symptoms of heart block and restores sufficient pumping function.
- the stimuli are electrical signals having amplitudes sufficient to cause impulses in the atrium of the heart to pass through the damaged His bundle to the ventricle of the heart yet the amplitude of these electrical signals are below a level required to excite the heart tissue.
- the electrical signal can be a constant current DC signal having a current amplitude sufficient to cause impulses in the atrium to pass through the damaged His bundle to the ventricle of the heart yet the amplitude of the constant current DC signal is below a level required to excite the heart tissue.
- the stimuli may be a train of current pulses with each pulse having an amplitude sufficient to cause impulses in the atrium of the heart to pass through the damaged His bundle to the ventricle of the heart and with each pulse having an amplitude below a level required to excite the heart tissue. Since the present invention particularly is adapted to be incorporated in a device implanted in a patient, the train of pulses is believed to be the preferable form of the stimuli sinoe less energy will be required per unit time and the power pack in the implanted apparatus should have a longer life span.
- susceptibility to heart block can be diagnosed by delivering the stimuli to the A-V junction in close proximity to the His bundle, when the stimuli are delivered to the heart and heart block symptoms are induced, a high susceptibility to spontaneously occurring heart block is indicated.
- the present invention is utilized to diagnose susceptibility to future or impending heart block in patients.
- FIG. 10 Diagrammatically shown in Figure 1 and designated therein by the general reference numeral 10 is a mammalian heart as seen through a right, lateral thoracotomy. It should be noted the experiments described herein were performed on an anesthetized dog. However, it should be emphasized that the present invention is particularly suitable for implanting in humans and the implantation procedures in humans are well known in the art.
- the abbreviation "SVC designates the superior vena cava
- the abbreviation “IVC” designates the inferior vena cava
- the abbreviation “SAN” designates the sino-atrial node
- the abbreviation “AVN” designates the atrio-ventricular node (sometimes referred to herein as the A-V node)
- the abbreviation “AO” designates the aorta
- the abbreviation "RA” designates the right atrium
- the abbreviation "BH” designates the bundle of His (sometimes referred to herein as the His bundle)
- the abbreviation “RV” designates the right ventricle. Together the A-V node and His bundle constitute the A-V junction.
- FIG. 2A Shown in Figure 2A is a bipolar electrode catheter with ring electrodes situated one centimeter apart. This electrode catheter is commercially available and commonly used in the art.
- Figure 2B shows a tripolar electrode catheter with the ring electrodes spaced one centimeter apart and this electrode catheter also is commercially available and commonly used in the art.
- Figure 2C shows a tripolar electrode catheter with a bipolar pair of electrodes at the tip situated one to two millimeters apart and a more proximal electrode ring one centimeter from the tip, and this electrode catheter is commercially available and commonly used in the art. Any of these electrode catheters is suitable for use in the present invention.
- a stimulus generator 12 is connected to the heart 10 by way of an electrode catheter 14.
- the electrode catheter 14, more particularly, is a bipolar electrode catheter of the type shown in Figure 2A in this particular application.
- the electrode catheter is inserted through a femoral vein and the tip of the electrode catheter 14 is positioned at the A-V junction in close approximation or apposition to the His bundle.
- the tip of the catheter 14 is stablized in this position in a manner well known in the art.
- the electrode catheter 14 is inserted into a peripheral vessel and positioned securely at the A-V junction in close proximity to the His bundle to record a specific signal from the His bundle and to deliver the stimuli to the heart.
- the His bundle is a structure of cardiac muscle through which all impulses from the atria (upper chambers) are conducted to the ventricles (lower chambers) of the heart and the site at which heart block has been shown to occur.
- the use of electrode catheters, such as the electrode catheter 14 for recording atrial and ventricle impulses and for delivering stimuli are well known in the art.
- the stimulus generator 12 is constructed and adapted to generate an output of continuous or intermittent stimuli in accordance with the present invention.
- One end of the electrode catheter 14 is connected to the stimulus generator 12 so that subthreshold stimuli may be outputted to the heart via the tip electrodes of catheter 14.
- the stimulus generator 12 is adjusted to output the subthreshold stimuli.
- Each patient's heart is different and the stimulus generator 12 must be adjusted after the electrode catheter 14 has been implanted and secured to the heart.
- the stimulus generator 12 is adjusted to output a stimulus at a level sufficient to excite the heart tissue at a rate just above the spontaneous heart rate.
- the level of the output stimulus is adjusted to a level just below the level required to excite the heart tissue, this being the stimulus to be outputted by the stimulus generator 12 in accordance with the present invention.
- the stimulus generator 12 outputs the subthreshold stimulus on a continuous basis and this stimulus is delivered to the A-V junction in close proximity to the His bundle. The delivery on a continuous basis of this subthreshold stimulus alleviates heart block and causes impulses in the atrium to pass to the ventricle via the damaged His bundle.
- the stimulus in one embodiment is a DC current signal and, in one other embodiment, the stimulus is a train of current pulses.
- each pulse in the train of pulses must be delivered to the heart at a time immediately following the atrial activation (P wave) .
- the electrode catheter 14a ( Figure 3B) delivers suprathreshold stimuli from the stimulus generator 12a at a rate just above the rate of the spontaneous heart rate.
- Each of these suprathreshold stimuli is outputted to the atrium and also to S 2 of the stimulus generator 12a.
- the latter is triggered to output a train of subthreshold stimuli to be delivered via catheter 14b to the A-V junction.
- These subthreshold stimuli are synchronously delivered just after each excited P wave and induces conduction to the ventricles through the damaged A-V junction.
- the present invention also can be utilized for diagnosing future susceptibility to a heart block.
- the electrode catheter is connected to the heart in a manner exactly like that described before.
- the stimulus generator generates and delivers the stimuli to the A-V junction in close proximity to the His bundle in a manner exactly like that described before.
- hidden or overt partial A-V conduction damage can be exacerbated by delivery of subthreshold stimuli to the damaged His bundle. If the delivery of the subthreshold stimuli to the heart induces heart block, this indicates future high susceptibility to spontaneous occurrence of heart block.
- the electrode catheter was connected to a dog's heart at the A-V junction in close proximity to the His bundle in a manner exactly like that described before in connection with Figure 1 and the electrode catheter was connected to a stimulus generator 12.
- the atrial and ventricular impulses were recorded as a standard electrocardiogram and a portion of this recording is shown in Figure 4 with one P wave being designated by the letter "P” in Figure 4 and one associated QRS wave being designated by the reference “R” in Figure 4.
- the first wave, as shown in Figure 4 and designated “L-2" is the electrocardiographic trace of lead II and the wave designated aVR in Figure 4 is the mirror image lead.
- the traces shown in Figure 4 reflect the normal state of the dog's heart prior to induction of damage to the A-V junction.
- the dog's heart was functioning in a normal manner.
- a stimulus comprising a 3 milliamp DC constant current was delivered to the A-V junction in close proximity to the His bundle at a time indicated by the arrow 20 in Figure 4 , the arrow 20 indicating the time at which the continuous DC current stimuli was initiated.
- the switching transient caused depolarization of the His bundle producing a
- QRS complex identical to the normal depolarization and the P- R interval was shortened. No excitatory effect was observed during the application of this DC stimulus until the break shock indicated via the arrow 22 in Figure 4 which again induced His bundle depolarization and a shortening of the P-R interval. With current levels between 4.5 mill lamps to 7.0 milliamps regular or intermittent His bundle excitation was not produced during the period of current application; thus , these levels were subthreshold. As indicated in Figure 4 , the delivery of the stimuli did not affect the normal functioning of the dog's heart in regard to inducing heart block.
- Shown in Figure 5 is an electrocardiographic trace of lead II (L-2 ) and aVR in a dog wherein the anterior septal artery that supplies the His bundle was tied off to produce a damaged His bundle due to low blood flow (ischemia) .
- ischemia low blood flow
- FIG 5 shows that there was a prolongation of the A-V conduction (increased duration of the P-R interval) and appearance of an incomplete right bundle branch block pattern in the QRS complex.
- a etlxulus comprising a 5 milliamp DC constant current was delivered at a time indicated by the arrow 24 in Figure 5.
- heart block was induced (P waves with no associated QRB complexes. This was removed at a time indicated by the arrow 26 in Figure 5. This indicates that the delivery of the subthreshold stimulus can induce heart block thereby indicating the future susceptibility of heart block in this particular heart and indicating the diagnostic effect of the present invention.
- the initial delivery of the stimulus at the time 24 induced excitation of the His bundle resulting in a ventricular complex similar in pattern to the previous spontaneous beats, within one beat, complete A-V block ensued (only P waves, no QRS c ⁇ mplexss) until a spontaneous ventricular escape beat occurred.
- Cessation of the stimulus at the time 26 permitted immediate resumption of a 1:1 A-V conduction.
- Another mode of subthreshold stimulation also resulted in reversion of A-V block to 1:1 A-V conduction.
- the atria were paced (indicated in Figure 7 by the designation "PI" which were the pacer impulses) by suprathreshold stimuli during complete heart block.
- These suprathreshold stimuli from S1 (in Figure 3B) triggered the delivery of a train of subthreshold stimuli from S2 at 80-90 Hz to the A-V junction through catheter 14a ( Figure 3B) .
- the train of subthreshold pulses were synchronized with each atrial driving stimulus and were set to occur 55 to 85 milliseconds after each driving stimulus.
- the stimulus generator 12 and the electrode catheter 14 both would be implanted in a human with an appropriate power pack to achieve the same results as the plug-in type of stimulator shown in Figure 3 and used in the laboratory experiments described before.
- the present invention provides a method for alleviating the symptoms of heart block which includes generating a subthreshold stimuli below a level required to excite the heart tissue and delivering the subthreshold stimuli to the heart. Regardless of where the heart block occurs, the subthreshold stimuli can be delivered at any position on the heart and alleviate the heart block by restoring and maintaining 1:1 conduction, as illustrated in Figure 8A and 8B. The subthreshold stimuli can be applied at sites remote from the specific blocked zone and still achieve the same correction of heart block.
- FIG 8A low blood flow to the bundle of His caused by ligation of the anterior septal artery (in the dog heart) resulted in heart block.
- the first two traces are standard electrocardiographic leads II (L-2) and aVR. These show that for every two depolarizations of the atria (A waves) only one ventricular depolarization (V) occurs. This is known as 2:1 A-V block. Localization of the A-V block was seen in the His bundle (Hb) trace. Note that in the first beat the Hb potential, which normally shows a good amplitude and compact activation time, now shows 2 portions H' and H" which are widely separated in time and markedly reduced in amplitude.
- the next beat shows failure of the cardiac impulse to cross the block so that the atria (A) and initial His bundle (H') are activated but the impulse does not depolarize the rest of the His bundle, nor the ventricles (no 2nd "V") occurred.
Abstract
A method for alleviating and diagnosing syndromes of heart block wherein a stimulus is continuously or intermittently delivered via a single electrode catheter at a site in a heart in close proximity to the A-V junction in the heart. The subthreshold stimuli were sufficient to cause impulses in the atrium to pass through the damaged his bundle to the ventricle and the stimuli were set at a level below a level required to excite the heart tissue. The delivery of the stimuli alleviates the symptoms of heart block. In one application, the delivery of the stimuli is used for diagnosing heart block when delivery of the stimuli induces the symptoms of heart block in the patient with partial or covert conduction disease.
Description
METHOD AND APPARATUS FOR ALLEVIATING AND
DIAGNOSING SYMPTOMS OF HEART BLOCK
FIELD OF THE INVENTION
The present invention generally relates to a method and apparatus for alleviating heart block by restoring and maintaining 1:1 conduction by delivering a subthreshold stimuli to the heart.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1 is a diagrammatic, schematic representation of a mammalian heart as seen through a right, lateral thoracotomy and showing the placement of an electrode catheter at the atrioventricular (A-V) junction in the region of the His bundle.
Figure 2A, 2B and 2C are diagrammatic representations of three catheters with ring electrodes at the tip and with the ring electrodes being spaced at various distances from the tip. The electrode catheters shown in Figure 2 constitute prior art electrode catheters which are suitable for use in the present invention for delivering subthreshold stimuli to the His bundle area.
Figure 3A is a schematic view of a stimulus generator and other components consisting of isolation and constant current units. Also shown is a diagram of the connection of the stimulus generator to the heart. The stimulus generator and components particularly shown in Figure 3A represent a laboratory model which was used to deliver stimuli in the form of a constant current DC pulse in the experiments described herein relating to the present invention.
Figure 3B is a diagrammatic view of the same generator and components modified to deliver trains of stimuli to the heart. The stimulus generator particularly shown in Figure 3B represents a laboratory model of a stimulus generator used in the experiments described herein relating to the present invention.
Figure 4 is a diagrammatic view shoving a recording of the electrical activity of a mammalian's normal functioning heart and illustrating that the delivery of the stimulus (a DC constant current signal) at the A-V junction in close proximity to the His bundle does not affect conduction through the A-V junction in the normal heart.
Figure 5 is a recording of the electrical activity of a mammalian's heart wherein the heart has been ischemically damaged due to anterior septal artery ligation and illustrating that the-delivery of the stimulus (a DC constant current signal) in accordance with the present invention induces heart block thereby indicating that this particular heart now is imminently susceptible to heart block.
Figure 6 is a recording of the electrical activity of amammalian's heart wherein the stimulus (a DC constant current signal) has been delivered at the A-V junction in close proximity to the His bundle in accordance with the present invention of the ischemically damaged heart after the predicted occurrence of a complete A-V heart block and illustrating that the delivery of the stimulus alleviates the symptoms of heart block by restoring 1:1 A-V conduction.
Figure- 7A, 7B and 7C are diagrammatic views of a recording of the electrical activity of a mammalian's heart with Figure 7B being a continuation from Figure 7A and with Figure 7C being a continuation of Figure 7B. Figure 7 illustrates that the delivery of the stimulus alleviates the
heart block symptoms, in a manner similar to that described before with respect to Figure 6, but the stimulus in this instance were more particularly a train of intermittent pulses rather than a continuous DC pulse,
Figure 8A, is a recording of electrical activity of a dog's heart wherein the first two traces are standard electrocardiographic leads II (L-2) and aVR and the second trace is the His bundle trace.
Figure 8B is a recording of electrical activity of a dog's heart where a subthreshold current was delivered to the right ventricular apex.
DESCRIPTION OF THE PREFERRED EMBODIMENTS
It is well known that in the heart block syndrome, also known as Stokes-Adams attacks, heart block occurs intermittently and abruptly or paroxysmally. The method of the present invention are utilized for alleviating the symptoms of heart block in one aspect, and the method of the present invention are utilized to diagnose future or impending susceptibility of heart block in one other aspect. In accordance with the method of the present Invention, a stimulus is continuously delivered via a single electrode catheter to the A-V junction in close proximity to the His bundle and the delivery of these stimuli alleviates the symptoms of heart block and restores sufficient pumping function.
The stimuli are electrical signals having amplitudes sufficient to cause impulses in the atrium of the heart to pass through the damaged His bundle to the ventricle of the heart yet the amplitude of these electrical signals are below a level required to excite the heart tissue. The electrical signal can be a constant current DC signal having a current amplitude sufficient to cause impulses in the atrium to pass
through the damaged His bundle to the ventricle of the heart yet the amplitude of the constant current DC signal is below a level required to excite the heart tissue. In one other embodiment, the stimuli may be a train of current pulses with each pulse having an amplitude sufficient to cause impulses in the atrium of the heart to pass through the damaged His bundle to the ventricle of the heart and with each pulse having an amplitude below a level required to excite the heart tissue. Since the present invention particularly is adapted to be incorporated in a device implanted in a patient, the train of pulses is believed to be the preferable form of the stimuli sinoe less energy will be required per unit time and the power pack in the implanted apparatus should have a longer life span.
In one embodiment, it has been found that susceptibility to heart block can be diagnosed by delivering the stimuli to the A-V junction in close proximity to the His bundle, when the stimuli are delivered to the heart and heart block symptoms are induced, a high susceptibility to spontaneously occurring heart block is indicated. Thus, in this embodiment, the present invention is utilized to diagnose susceptibility to future or impending heart block in patients.
Diagrammatically shown in Figure 1 and designated therein by the general reference numeral 10 is a mammalian heart as seen through a right, lateral thoracotomy. It should be noted the experiments described herein were performed on an anesthetized dog. However, it should be emphasized that the present invention is particularly suitable for implanting in humans and the implantation procedures in humans are well known in the art. As shown in Figure 1, the abbreviation "SVC designates the superior vena cava; the abbreviation "IVC" designates the inferior vena cava; the abbreviation
"SAN" designates the sino-atrial node; the abbreviation "AVN" designates the atrio-ventricular node (sometimes referred to herein as the A-V node); the abbreviation "AO" designates the aorta; the abbreviation "RA" designates the right atrium; the abbreviation "BH" designates the bundle of His (sometimes referred to herein as the His bundle); the abbreviation "RV" designates the right ventricle. Together the A-V node and His bundle constitute the A-V junction.
Shown in Figure 2A is a bipolar electrode catheter with ring electrodes situated one centimeter apart. This electrode catheter is commercially available and commonly used in the art. Figure 2B shows a tripolar electrode catheter with the ring electrodes spaced one centimeter apart and this electrode catheter also is commercially available and commonly used in the art. Figure 2C shows a tripolar electrode catheter with a bipolar pair of electrodes at the tip situated one to two millimeters apart and a more proximal electrode ring one centimeter from the tip, and this electrode catheter is commercially available and commonly used in the art. Any of these electrode catheters is suitable for use in the present invention.
In the present state of the art there are other electrode catheters which consist of screw-in leads so that the tip of the catheter can be affixed to the cardiac muscle at various sites in the heart. Such anchored catheters can be used for chronic pacing whereas the wedged catheter placement herein is for the purpose of description in acute applications of the new pacing modality.
As shown in Figure 1, a stimulus generator 12 is connected to the heart 10 by way of an electrode catheter 14. The electrode catheter 14, more particularly, is a bipolar electrode catheter of the type shown in Figure 2A in this
particular application. The electrode catheter is inserted through a femoral vein and the tip of the electrode catheter 14 is positioned at the A-V junction in close approximation or apposition to the His bundle. The tip of the catheter 14 is stablized in this position in a manner well known in the art.
In general, the electrode catheter 14 is inserted into a peripheral vessel and positioned securely at the A-V junction in close proximity to the His bundle to record a specific signal from the His bundle and to deliver the stimuli to the heart. The His bundle is a structure of cardiac muscle through which all impulses from the atria (upper chambers) are conducted to the ventricles (lower chambers) of the heart and the site at which heart block has been shown to occur. The use of electrode catheters, such as the electrode catheter 14 for recording atrial and ventricle impulses and for delivering stimuli are well known in the art.
The stimulus generator 12 is constructed and adapted to generate an output of continuous or intermittent stimuli in accordance with the present invention.
One end of the electrode catheter 14 is connected to the stimulus generator 12 so that subthreshold stimuli may be outputted to the heart via the tip electrodes of catheter 14.
After securing the electrode catheter 14 to the heart
(Figure 3A), the stimulus generator 12 is adjusted to output the subthreshold stimuli. Each patient's heart is different and the stimulus generator 12 must be adjusted after the electrode catheter 14 has been implanted and secured to the heart. Initially, the stimulus generator 12 is adjusted to output a stimulus at a level sufficient to excite the heart tissue at a rate just above the spontaneous heart rate. After outputting this stimulus at a level sufficient to excite the heart tissue, the level of the output stimulus is adjusted to
a level just below the level required to excite the heart tissue, this being the stimulus to be outputted by the stimulus generator 12 in accordance with the present invention. Once adjusted, the stimulus generator 12 outputs the subthreshold stimulus on a continuous basis and this stimulus is delivered to the A-V junction in close proximity to the His bundle. The delivery on a continuous basis of this subthreshold stimulus alleviates heart block and causes impulses in the atrium to pass to the ventricle via the damaged His bundle.
As mentioned before, the stimulus in one embodiment is a DC current signal and, in one other embodiment, the stimulus is a train of current pulses. When delivering a train of pulses, each pulse in the train of pulses must be delivered to the heart at a time immediately following the atrial activation (P wave) . The electrode catheter 14a (Figure 3B) delivers suprathreshold stimuli from the stimulus generator 12a at a rate just above the rate of the spontaneous heart rate. Each of these suprathreshold stimuli is outputted to the atrium and also to S2 of the stimulus generator 12a. The latter is triggered to output a train of subthreshold stimuli to be delivered via catheter 14b to the A-V junction. These subthreshold stimuli are synchronously delivered just after each excited P wave and induces conduction to the ventricles through the damaged A-V junction.
As mentioned before, the present invention also can be utilized for diagnosing future susceptibility to a heart block. In this embodiment, the electrode catheter is connected to the heart in a manner exactly like that described before. The stimulus generator generates and delivers the stimuli to the A-V junction in close proximity to the His bundle in a manner exactly like that described before.
In this diagnostic application, hidden or overt partial A-V conduction damage can be exacerbated by delivery of subthreshold stimuli to the damaged His bundle. If the delivery of the subthreshold stimuli to the heart induces heart block, this indicates future high susceptibility to spontaneous occurrence of heart block. It has been found that, the delivery of subthreshold stimuli to the A-V junction, in a normal functioning heart which is not susceptible to heart block, will not affect the beating of the heart and normal atrial and ventricular sequential activation will be unaffected. On the other hand, if the delivery of the stimuli to the heart induces heart block as indicated by the received atrial and ventricular recordings, future high susceptibility to heart block is indicated and may be diagnosed.
In experiments, the electrode catheter was connected to a dog's heart at the A-V junction in close proximity to the His bundle in a manner exactly like that described before in connection with Figure 1 and the electrode catheter was connected to a stimulus generator 12. The atrial and ventricular impulses were recorded as a standard electrocardiogram and a portion of this recording is shown in Figure 4 with one P wave being designated by the letter "P" in Figure 4 and one associated QRS wave being designated by the reference "R" in Figure 4. The first wave, as shown in Figure 4 and designated "L-2" is the electrocardiographic trace of lead II and the wave designated aVR in Figure 4 is the mirror image lead. The traces shown in Figure 4 reflect the normal state of the dog's heart prior to induction of damage to the A-V junction.
As indicated in Figure 4 , the dog's heart was functioning in a normal manner. A stimulus comprising a 3 milliamp DC
constant current was delivered to the A-V junction in close proximity to the His bundle at a time indicated by the arrow 20 in Figure 4 , the arrow 20 indicating the time at which the continuous DC current stimuli was initiated. The switching transient caused depolarization of the His bundle producing a
QRS complex, identical to the normal depolarization and the P- R interval was shortened. No excitatory effect was observed during the application of this DC stimulus until the break shock indicated via the arrow 22 in Figure 4 which again induced His bundle depolarization and a shortening of the P-R interval. With current levels between 4.5 mill lamps to 7.0 milliamps regular or intermittent His bundle excitation was not produced during the period of current application; thus , these levels were subthreshold. As indicated in Figure 4 , the delivery of the stimuli did not affect the normal functioning of the dog's heart in regard to inducing heart block.
Shown in Figure 5 is an electrocardiographic trace of lead II (L-2 ) and aVR in a dog wherein the anterior septal artery that supplies the His bundle was tied off to produce a damaged His bundle due to low blood flow (ischemia) . As shown in Figure 5 , there was a prolongation of the A-V conduction (increased duration of the P-R interval) and appearance of an incomplete right bundle branch block pattern in the QRS complex. These changes were the result of ligation of the anterior septal coronary artery which supplies the region of the A-V junction and causes damage due to reduce blood flow to this region. A etlxulus comprising a 5 milliamp DC constant current was delivered at a time indicated by the arrow 24 in Figure 5. With the delivery of the stimulus at the time 24 , heart block was induced (P waves with no associated QRB complexes. This was removed at a time indicated by the arrow 26 in Figure 5. This indicates that the delivery of the
subthreshold stimulus can induce heart block thereby indicating the future susceptibility of heart block in this particular heart and indicating the diagnostic effect of the present invention. The initial delivery of the stimulus at the time 24 induced excitation of the His bundle resulting in a ventricular complex similar in pattern to the previous spontaneous beats, within one beat, complete A-V block ensued (only P waves, no QRS cαmplexss) until a spontaneous ventricular escape beat occurred. Cessation of the stimulus at the time 26 permitted immediate resumption of a 1:1 A-V conduction.
Several minutes after the experiment just described and as a result of progressive ischemia (low blood flow) at the A-V junction, spontaneous complete heart block occurred in which repetitive and regular P waves were intermittently in -terrupted by escape ventricular beats at a very slow rate, as is indicated in Figure 6. When the stimulus (a 5 milliamp DC constant current signal) was applied at a time 28 (Figure 6), 1:1 A-V conduction resulted, showing the previous right bundle branch block pattern. With the cessation of the subthreshold stimulus at a time 30 (Figure 6) a single His bundle activation occurred as the result of the break shock and was followed by resumption of complete heart block. Re-establishment of 1:1 A-V conduαtion was maintained as long as the subthreshold stimulus (DC current) was maintained. The longest time during which such stimulation was maintained during these experiments was one hour with continuous 1:1 conduction. Cessation of the stimulus resulted in return of heart block within 4 to 5 beats.
Another mode of subthreshold stimulation also resulted in reversion of A-V block to 1:1 A-V conduction. In this mode, the atria were paced (indicated in Figure 7 by the designation
"PI" which were the pacer impulses) by suprathreshold stimuli during complete heart block. These suprathreshold stimuli from S1 (in Figure 3B) triggered the delivery of a train of subthreshold stimuli from S2 at 80-90 Hz to the A-V junction through catheter 14a (Figure 3B) . The train of subthreshold pulses were synchronized with each atrial driving stimulus and were set to occur 55 to 85 milliseconds after each driving stimulus. At a level of 4.5 milliamps applied to the damaged His bundle through catheter 14b (arrow, 30 ) 1:1 A-V conduction was restored and maintained with a right bundle branch block morphology shown on the ECG (Figures 7λ and 7B) . Reduction of the subthreshold train current to 4.0 milliamps (arrow 32, end of Figure 7B) lead to 3:1 A-V conduction with right bundle branch block patterns in the conducted beats (Figure 7C) . Cessation of the stimuli was immediately followed by A-V block while suprathreshold stimuli continued to drive the atria at 180 beats per minute (same as beginning of Figure 7A) .
It is contemplated that with appropriate miniaturization, the stimulus generator 12 and the electrode catheter 14 both would be implanted in a human with an appropriate power pack to achieve the same results as the plug-in type of stimulator shown in Figure 3 and used in the laboratory experiments described before.
The present invention provides a method for alleviating the symptoms of heart block which includes generating a subthreshold stimuli below a level required to excite the heart tissue and delivering the subthreshold stimuli to the heart. Regardless of where the heart block occurs, the subthreshold stimuli can be delivered at any position on the heart and alleviate the heart block by restoring and maintaining 1:1 conduction, as illustrated in Figure 8A and 8B. The subthreshold stimuli can be applied at sites remote
from the specific blocked zone and still achieve the same correction of heart block.
In Figure 8A, low blood flow to the bundle of His caused by ligation of the anterior septal artery (in the dog heart) resulted in heart block. The first two traces are standard electrocardiographic leads II (L-2) and aVR. These show that for every two depolarizations of the atria (A waves) only one ventricular depolarization (V) occurs. This is known as 2:1 A-V block. Localization of the A-V block was seen in the His bundle (Hb) trace. Note that in the first beat the Hb potential, which normally shows a good amplitude and compact activation time, now shows 2 portions H' and H" which are widely separated in time and markedly reduced in amplitude. The next beat shows failure of the cardiac impulse to cross the block so that the atria (A) and initial His bundle (H') are activated but the impulse does not depolarize the rest of the His bundle, nor the ventricles (no 2nd "V") occurred.
In Figure 8B subthreshold current at 3.0 ma was delivered in the form of a constant DC pulse to the right ventricular apex. This site is 4-6 centimeters distant from the His bundle, i.e., the site of the A-V block. Yet, during the delivery of the constant current, upper part of Figure 8B 1:1 A-V conduction was induced. In the lower part of the panel the current was terminated (indicated by the baseline shift, DC off) and within 4 beats 2:1 A-V block returned.
Changes may be made in the construction and the operation of the various components and assemblies described herein and changes may be made in the steps or sequence of steps of the methods described herein without departing from the spirit and the scope of the invention as defined in the following claims.
Claims
1. A method for alleviating the symptoms of heart block comprising:
generating a subthreshold stimuli below a level required to excite the heart tissue; and
delivering the subthreshold stimuli to the heart for alleviating heart block by restoring and maintaining 1:1 conduction.
2. The method of claim 1 wherein the subthreshold stimuli are delivered continuously or intermittently.
3. The method of claim 1 wherein the step of delivering the stimuli further comprises:
connecting one end of an electrode catheter to the heart and connecting the opposite end of the electrode catheter for receiving the subthreshold stimuli; and
conducting the subthreshold stimuli through the electrode catheter and delivering the stimuli to the heart via the connection of the one end of the electrode catheter to the heart.
4. The method of claim 1 wherein the stimuli is a DC current having an amplitude sufficient to cause impulses in the atrium to pass to the ventricle and the amplitude being below a level required to excite the heart tissue.
5. The method of claim 1 wherein the stimuli is a train of pulses with each pulse having an amplitude sufficient to cause impulses in the atrium to pass to the ventricle and the amplitude being below a level required to excite the heart tissue.
6. The method of claim 5 in the step of delivering the stimuli to the heart further comprising:
sensing atrial impulses of the heart; and delivering each pulse in the train of pulses to the heart at a time immediately following an atrial impulse (P wave).
7. An apparatus for alleviating the symptoms of heart block comprising:
means for generating a subthreshold stimuli below a level required to excite the heart tissue; and
means for delivering the subthreshold stimuli to the heart for alleviating heart block by restoring and maintaining 1:1 conduction.
8. The apparatus of Claim 7 wherein the subthreshold stimuli are delivered continuously or intermittently.
9. The apparatus of Claims 7 or 8 wherein the means for delivering the stimuli further comprises:
means for connecting one end of ah electrode catheter to the heart and connecting the opposite end of the electrode catheter for receiving the subthreshold stimuli; and means for conducting the subthreshold stimuli through the electrode catheter and delivering the stimuli to the heart via the connection of the one end of the electrode catheter to the heart.
10. The apparatus of any one of Claims 7 through 9 wherein the stimuli is a DC current having an amplitude sufficient to cause impulses in the atrium to pass to the ventricle and the amplitude being below a level required to excite the heart tissue.
11. The apparatus of any one of Claims 7 through 9 wherein the stimuli is a train of pulses with each pulse having an amplitude sufficient to cause impulses in the atrium to pass to the ventricle and the amplitude being below a level required to excite the heart tissue.
12. The apparatus of Claim 11 wherein the means for delivering the stimuli to the heart further comprises:
means for sensing atrial impulses of the heart; and
means for delivering each pulse in the train of pulses to the heart at a time immediately following an atrial impulse (P wave).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US823,500 | 1992-01-22 | ||
US07/823,500 US5320642A (en) | 1990-06-01 | 1992-01-22 | Method for alleviating and diagnosing symptoms of heart block |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1993014814A1 true WO1993014814A1 (en) | 1993-08-05 |
Family
ID=25238939
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1993/000509 WO1993014814A1 (en) | 1992-01-22 | 1993-01-21 | Method and apparatus for alleviating and diagnosing symptoms of heart block |
Country Status (3)
Country | Link |
---|---|
US (1) | US5320642A (en) |
AU (1) | AU3480693A (en) |
WO (1) | WO1993014814A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998014241A1 (en) * | 1996-10-03 | 1998-04-09 | Medtronic, Inc. | System for providing hyperpolarization of cardiac cells to enhance cardiac function |
Families Citing this family (69)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5782873A (en) * | 1995-10-11 | 1998-07-21 | Trustees Of Boston University | Method and apparatus for improving the function of sensory cells |
JP4175662B2 (en) | 1996-01-08 | 2008-11-05 | インパルス ダイナミクス エヌ.ヴイ. | Electric muscle control device |
IL125424A0 (en) | 1998-07-20 | 1999-03-12 | New Technologies Sa Ysy Ltd | Pacing with hemodynamic enhancement |
US7167748B2 (en) * | 1996-01-08 | 2007-01-23 | Impulse Dynamics Nv | Electrical muscle controller |
US8321013B2 (en) | 1996-01-08 | 2012-11-27 | Impulse Dynamics, N.V. | Electrical muscle controller and pacing with hemodynamic enhancement |
IL125136A (en) * | 1996-01-08 | 2003-07-31 | Impulse Dynamics Nv | Electrical cardiac muscle controller method and apparatus |
US8825152B2 (en) | 1996-01-08 | 2014-09-02 | Impulse Dynamics, N.V. | Modulation of intracellular calcium concentration using non-excitatory electrical signals applied to the tissue |
US9289618B1 (en) | 1996-01-08 | 2016-03-22 | Impulse Dynamics Nv | Electrical muscle controller |
US6415178B1 (en) * | 1996-09-16 | 2002-07-02 | Impulse Dynamics N.V. | Fencing of cardiac muscles |
US20020032467A1 (en) * | 2000-05-04 | 2002-03-14 | Itsik Shemer | Signal delivery through the right ventricular septum |
US9713723B2 (en) | 1996-01-11 | 2017-07-25 | Impulse Dynamics Nv | Signal delivery through the right ventricular septum |
US7840264B1 (en) | 1996-08-19 | 2010-11-23 | Mr3 Medical, Llc | System and method for breaking reentry circuits by cooling cardiac tissue |
US6341235B1 (en) * | 1996-08-19 | 2002-01-22 | Mower Chf Treatment Irrevocable Trust | Augmentation of electrical conduction and contractility by biphasic cardiac pacing administered via the cardiac blood pool |
US7908003B1 (en) | 1996-08-19 | 2011-03-15 | Mr3 Medical Llc | System and method for treating ischemia by improving cardiac efficiency |
US7006871B1 (en) | 1997-07-16 | 2006-02-28 | Metacure N.V. | Blood glucose level control |
ATE353689T1 (en) | 1997-07-16 | 2007-03-15 | Metacure Nv | DEVICE FOR CONTROLLING A SMOOTH MUSCLE |
EP2208782B1 (en) * | 1999-02-04 | 2017-05-31 | Pluristem Ltd. | Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells |
US8700161B2 (en) | 1999-03-05 | 2014-04-15 | Metacure Limited | Blood glucose level control |
US8019421B2 (en) * | 1999-03-05 | 2011-09-13 | Metacure Limited | Blood glucose level control |
US9101765B2 (en) * | 1999-03-05 | 2015-08-11 | Metacure Limited | Non-immediate effects of therapy |
US8666495B2 (en) | 1999-03-05 | 2014-03-04 | Metacure Limited | Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar |
US8346363B2 (en) | 1999-03-05 | 2013-01-01 | Metacure Limited | Blood glucose level control |
US6256537B1 (en) * | 1999-03-17 | 2001-07-03 | Medtronic, Inc. | Pacemaker system with inhibition of AV node for rate regulation during atrial fibrillation |
US6560489B2 (en) | 1999-08-24 | 2003-05-06 | Em Vascular, Inc. | Therapeutic device and method for treating diseases of cardiac muscle |
US6556872B2 (en) * | 1999-08-24 | 2003-04-29 | Ev Vascular, Inc. | Therapeutic device and method for treating diseases of cardiac muscle |
AU7811700A (en) * | 1999-10-04 | 2001-05-10 | Impulse Dynamics N.V. | Modulation of intracellular calcium concentration using non-excitatory electrical signals applied to the tissue |
AU1049901A (en) | 1999-10-25 | 2001-05-08 | Impulse Dynamics N.V. | Cardiac contractility modulation device having anti-arrhythmic capabilities and a method of operating thereof |
US7027863B1 (en) | 1999-10-25 | 2006-04-11 | Impulse Dynamics N.V. | Device for cardiac therapy |
US6993385B1 (en) * | 1999-10-25 | 2006-01-31 | Impulse Dynamics N.V. | Cardiac contractility modulation device having anti-arrhythmic capabilities and a method of operating thereof |
US6609027B2 (en) * | 2001-02-23 | 2003-08-19 | Pacesetter, Inc. | His Bundle sensing device and associated method |
US6718206B2 (en) | 2001-10-23 | 2004-04-06 | Medtronic, Inc. | Permanent atrial-his-ventricular sequential pacing |
US7177704B2 (en) * | 2002-04-29 | 2007-02-13 | Medtronic, Inc. | Pacing method and apparatus |
US7400931B2 (en) * | 2002-09-18 | 2008-07-15 | Cardiac Pacemakers, Inc. | Devices and methods to stimulate therapeutic angiogenesis for ischemia and heart failure |
WO2004070396A2 (en) | 2003-02-10 | 2004-08-19 | N-Trig Ltd. | Touch detection for a digitizer |
US7840262B2 (en) | 2003-03-10 | 2010-11-23 | Impulse Dynamics Nv | Apparatus and method for delivering electrical signals to modify gene expression in cardiac tissue |
US11439815B2 (en) | 2003-03-10 | 2022-09-13 | Impulse Dynamics Nv | Protein activity modification |
US8792985B2 (en) | 2003-07-21 | 2014-07-29 | Metacure Limited | Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar |
US7245973B2 (en) | 2003-12-23 | 2007-07-17 | Cardiac Pacemakers, Inc. | His bundle mapping, pacing, and injection lead |
US11779768B2 (en) | 2004-03-10 | 2023-10-10 | Impulse Dynamics Nv | Protein activity modification |
US8352031B2 (en) | 2004-03-10 | 2013-01-08 | Impulse Dynamics Nv | Protein activity modification |
DE202004009224U1 (en) * | 2004-06-14 | 2004-08-12 | Isra Vision Systems Ag | Sensor for measuring the surface of an object |
EP1827571B1 (en) | 2004-12-09 | 2016-09-07 | Impulse Dynamics NV | Protein activity modification |
US8010191B2 (en) | 2004-12-20 | 2011-08-30 | Cardiac Pacemakers, Inc. | Systems, devices and methods for monitoring efficiency of pacing |
AR047851A1 (en) | 2004-12-20 | 2006-03-01 | Giniger Alberto German | A NEW MARCAPASOS THAT RESTORES OR PRESERVES THE PHYSIOLOGICAL ELECTRIC DRIVING OF THE HEART AND A METHOD OF APPLICATION |
US8005544B2 (en) | 2004-12-20 | 2011-08-23 | Cardiac Pacemakers, Inc. | Endocardial pacing devices and methods useful for resynchronization and defibrillation |
US8290586B2 (en) | 2004-12-20 | 2012-10-16 | Cardiac Pacemakers, Inc. | Methods, devices and systems for single-chamber pacing using a dual-chamber pacing device |
US8010192B2 (en) * | 2004-12-20 | 2011-08-30 | Cardiac Pacemakers, Inc. | Endocardial pacing relating to conduction abnormalities |
US8050756B2 (en) * | 2004-12-20 | 2011-11-01 | Cardiac Pacemakers, Inc. | Circuit-based devices and methods for pulse control of endocardial pacing in cardiac rhythm management |
US8014861B2 (en) * | 2004-12-20 | 2011-09-06 | Cardiac Pacemakers, Inc. | Systems, devices and methods relating to endocardial pacing for resynchronization |
US8423139B2 (en) | 2004-12-20 | 2013-04-16 | Cardiac Pacemakers, Inc. | Methods, devices and systems for cardiac rhythm management using an electrode arrangement |
US8326423B2 (en) | 2004-12-20 | 2012-12-04 | Cardiac Pacemakers, Inc. | Devices and methods for steering electrical stimulation in cardiac rhythm management |
US9821158B2 (en) | 2005-02-17 | 2017-11-21 | Metacure Limited | Non-immediate effects of therapy |
WO2006097934A2 (en) | 2005-03-18 | 2006-09-21 | Metacure Limited | Pancreas lead |
EP1898991B1 (en) | 2005-05-04 | 2016-06-29 | Impulse Dynamics NV | Protein activity modification |
US8688234B2 (en) | 2008-12-19 | 2014-04-01 | Cardiac Pacemakers, Inc. | Devices, methods, and systems including cardiac pacing |
US8386038B2 (en) * | 2009-07-01 | 2013-02-26 | Stefano Bianchi | Vagal stimulation during atrial tachyarrhythmia to facilitate cardiac resynchronization therapy |
US8934975B2 (en) | 2010-02-01 | 2015-01-13 | Metacure Limited | Gastrointestinal electrical therapy |
US8565880B2 (en) | 2010-04-27 | 2013-10-22 | Cardiac Pacemakers, Inc. | His-bundle capture verification and monitoring |
US8406868B2 (en) | 2010-04-29 | 2013-03-26 | Medtronic, Inc. | Therapy using perturbation and effect of physiological systems |
US8639327B2 (en) | 2010-04-29 | 2014-01-28 | Medtronic, Inc. | Nerve signal differentiation in cardiac therapy |
US8620425B2 (en) | 2010-04-29 | 2013-12-31 | Medtronic, Inc. | Nerve signal differentiation in cardiac therapy |
US8788028B2 (en) | 2010-07-28 | 2014-07-22 | Medtronic, Inc. | Parasympathetic stimulation to enhance tachyarrhythmia detection |
US8718763B2 (en) | 2011-01-19 | 2014-05-06 | Medtronic, Inc. | Vagal stimulation |
US8781582B2 (en) | 2011-01-19 | 2014-07-15 | Medtronic, Inc. | Vagal stimulation |
US8706223B2 (en) | 2011-01-19 | 2014-04-22 | Medtronic, Inc. | Preventative vagal stimulation |
US8725259B2 (en) | 2011-01-19 | 2014-05-13 | Medtronic, Inc. | Vagal stimulation |
US8781583B2 (en) | 2011-01-19 | 2014-07-15 | Medtronic, Inc. | Vagal stimulation |
WO2012125273A2 (en) | 2011-03-14 | 2012-09-20 | Cardiac Pacemakers, Inc. | His capture verification using electro-mechanical delay |
US9433791B2 (en) | 2011-05-11 | 2016-09-06 | Medtronic, Inc. | AV nodal stimulation during atrial tachyarrhythmia to prevent inappropriate therapy delivery |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4041953A (en) * | 1974-04-12 | 1977-08-16 | Cardiac Pacemakers, Inc. | Cardiac pacer circuit |
US4543963A (en) * | 1983-11-22 | 1985-10-01 | Gessman Lawrence J | Method and apparatus for differentiating antegrade from retrograde P-waves and for preventing pacemaker generated tachycardia |
US4554922A (en) * | 1982-09-30 | 1985-11-26 | Prystowsky Eric N | Method of inhibiting cardiac arrhythmias |
EP0241102A2 (en) * | 1982-11-22 | 1987-10-14 | Intermedics, Inc. | A heart pacemaker |
US5083564A (en) * | 1990-06-01 | 1992-01-28 | Board Of Regents Of The University Of Oklahoma | Method for alleviating and diagnosing symptoms of heart block |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3253596A (en) * | 1963-05-27 | 1966-05-31 | Cordis Corp | Cardiac pacer |
FR2248020B1 (en) * | 1973-10-18 | 1977-05-27 | Pequignot Michel | |
US4055189A (en) * | 1975-05-19 | 1977-10-25 | Medalert Corporation | Condition monitoring pacer |
ES226859Y (en) * | 1977-03-03 | 1977-11-16 | RHYTHM CONTROLLED CARDIAC PACEMAKERS BY REGULATORY SIGNALS DETECTED IN THE TRUNKS AND NOT THE NERVOUS RECEPTORS. | |
US4222386A (en) * | 1979-03-26 | 1980-09-16 | Smolnikov Leonid E | Method for stimulating cardiac action by means of implanted _electrocardiostimulator and implantable electrocardiostimulator for effecting same |
US4305396A (en) * | 1979-04-16 | 1981-12-15 | Vitatron Medical B.V. | Rate adaptive pacemaker and method of cardiac pacing |
US4579119A (en) * | 1983-11-18 | 1986-04-01 | Cordis Corporation | Method and apparatus for multiplexed dipole/quadrupole for stimulation/sensing |
US4577634A (en) * | 1983-11-22 | 1986-03-25 | Gessman Lawrence J | Method and apparatus for alleviating paroxysmal atrail tachycardia |
-
1992
- 1992-01-22 US US07/823,500 patent/US5320642A/en not_active Expired - Fee Related
-
1993
- 1993-01-21 AU AU34806/93A patent/AU3480693A/en not_active Abandoned
- 1993-01-21 WO PCT/US1993/000509 patent/WO1993014814A1/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4041953A (en) * | 1974-04-12 | 1977-08-16 | Cardiac Pacemakers, Inc. | Cardiac pacer circuit |
US4554922A (en) * | 1982-09-30 | 1985-11-26 | Prystowsky Eric N | Method of inhibiting cardiac arrhythmias |
EP0241102A2 (en) * | 1982-11-22 | 1987-10-14 | Intermedics, Inc. | A heart pacemaker |
US4543963A (en) * | 1983-11-22 | 1985-10-01 | Gessman Lawrence J | Method and apparatus for differentiating antegrade from retrograde P-waves and for preventing pacemaker generated tachycardia |
US5083564A (en) * | 1990-06-01 | 1992-01-28 | Board Of Regents Of The University Of Oklahoma | Method for alleviating and diagnosing symptoms of heart block |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998014241A1 (en) * | 1996-10-03 | 1998-04-09 | Medtronic, Inc. | System for providing hyperpolarization of cardiac cells to enhance cardiac function |
Also Published As
Publication number | Publication date |
---|---|
AU3480693A (en) | 1993-09-01 |
US5320642A (en) | 1994-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5320642A (en) | Method for alleviating and diagnosing symptoms of heart block | |
US5083564A (en) | Method for alleviating and diagnosing symptoms of heart block | |
EP0727241B1 (en) | Device for heart stimulation | |
AU769902B2 (en) | Antitachycardial pacing | |
US9962548B2 (en) | Closed loop neural stimulation synchronized to cardiac cycles | |
US5735876A (en) | Electrical cardiac output forcing method and apparatus for an atrial defibrillator | |
US6122553A (en) | Method and apparatus for treating cardiac arrhythmia | |
JP5227971B2 (en) | Nerve stimulation system | |
JP4163855B2 (en) | System to remove atrial fibrillation by double shock | |
US6701187B1 (en) | Implantable cardiac stimulation device and method for prolonging atrial refractoriness | |
US5391185A (en) | Atrial cardioverter with ventricular protection | |
US20100249860A1 (en) | External cardiac stimulation patch | |
JPH07136287A (en) | Implamtable dual-chamber pace maker | |
WO1993021824A1 (en) | Implantable electrical vagal stimulation for prevention or interruption of life threatening arrhythmias | |
JPH06233828A (en) | Antiarhythmia pacemaker and method of heart stimulation | |
WO2004012810A1 (en) | Subminiature integrated heart pace maker and dispersed heart pacing system | |
CN111954555A (en) | Automatic threshold testing for bundle of his pacing | |
JP2001520093A (en) | Implantable heart stimulator for rate-adaptive T-wave detection | |
US8983600B2 (en) | Method and apparatus for safety control during cardiac pacing mode transition | |
Bonnabeau Jr et al. | OBSERVATIONS ON SUDDEN DEATH DURING PACEMAKER STIMULATION IN COMPLETE ATRIOVENTRICULAR BLOCK: Leading to the Development of a “P-Wave” Pacemaker without Atrial Leads | |
Barold et al. | Oversensing by single-chamber pacemakers: mechanisms, diagnosis, and treatment | |
Estes III et al. | External cardiac programmed stimulation for noninvasive termination of sustained supraventricular and ventricular tachycardia | |
DULK et al. | Management of pacemaker circus movement tachycardias | |
US8086307B2 (en) | Terminating tachyarrhythmias | |
Nathan et al. | Double ventricular pacing in a patient with a “DDD” universal pacemaker |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
122 | Ep: pct application non-entry in european phase |